Screener
Emergent Biosolutions EBS EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Emergent Biosolutions’s reported figures.
Based on trailing twelve months.
The source filing: Emergent Biosolutions’s 10-Q, filed October 30, 2025. Open the filing →
- Filed
- Oct 30, 2025
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q3 2025
- Accession
- 0001367644-25-000202
FAQ
- What is Emergent Biosolutions's EBITDA margin?
- Emergent Biosolutions (EBS) reported EBITDA margin of 27.5% in Q3 2025.
- How has Emergent Biosolutions's EBITDA margin changed year-over-year?
- Emergent Biosolutions's EBITDA margin increased by 1110.8% year-over-year, from -2.7% to 27.5%.
- What is the long-term trend for Emergent Biosolutions's EBITDA margin?
- Over 4 years (2020 to 2024), Emergent Biosolutions's EBITDA margin has grown at a -87.2% compound annual growth rate (CAGR), from 36.2% to 0%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about Emergent Biosolutions's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude